Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy

W. Y. Kao, Y. Y. Chiou*, H. H. Hung, C. W. Su, Y. H. Chou, J. C. Wu, T. I. Huo, Y. H. Huang, W. C. Wu, H. C. Lin, S. D. Lee

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences